| 摘要 |
This retrospective review underscores Dr. Shao-Wei Chen's significant contributions to aortic disease research, utilizing big data analytics to advance understanding and optimize treatment outcomes. With a focus on aortic dissection and aneurysm management, Dr. Chen 's studies cover a range of critical topics, including genetic predisposition, pharmacologic impacts, and procedural approaches. His research highlights the strong correlation between family history and early-onset aortic disease, underscoring the importance of
screening and personalized interventions for genetically at-risk populations. Notably, his work has demonstrated the adverse effects of fluoroquinolones on aortic outcomes, revealing increased mortality and complication rates, which has implications for clinical guidelines on medication management in aortic patients. Dr. Chen's comparative analyses of endovascular versus open repair for aortic conditions, such as traumatic thoracic aortic injuries, suggest superior outcomes with endovascular approaches for certain high-risk patients, offering
insights that support tailored procedural choices. Additionally, his translational research into the role of lumican in aortic pathology adds a valuable dimension to understanding connective tissue integrity and potential biomarker applications, bridging the gap between basic science discoveries and clinical care. Dr. Chen's work advances the field of aortic disease through interdisciplinary collaboration, large-scale data analysis, and translational research. Future studies should continue refining surgical techniques, investigating innovative therapeutic strategies, and integrating advanced analytics to further enhance patient-specific care and improve long-term outcomes in aortic disease management. |
